Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization andin vivoevaluation
Authors:
- Sandipan DasguptaSDSandipan Dasgupta
- Sanjay DeySDSanjay Dey
- Supratik ChoudhurySCSupratik Choudhury
- Bhaskar MazumderBMBhaskar Mazumder
- 15 January 2013
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 10 (4) , 411-420
Abstract
The aim of the present study was to investigate the potential of a nanoemulsion for topical delivery of aceclofenac using different excipients having optimum emulsifying ability rather than their solubilizing capacity. The oil-in-water nanoemulsions were prepared by screening the excipients from the nanoemulsion region of pseudoternary phase diagram. The prepared nanoemulsions were subjected to different thermodynamic stability tests. The nanoemulsion formulations that passed thermodynamic stability tests were characterized for viscosity, droplet size, transmission electron microscopy, refractive index and in vitro skin permeation. The in vitro skin permeation profile of optimized nanoemulsion formulation (NE31, containing 23.85% Polyoxy-35-castor oil, 7.95% PEG 400 and 13.6% Triacetin) was compared with that of nanoemulsion gel (NG31) and marketed gel formulation (HIFENAC GEL (HIG)). In vivo anti-inflammatory efficacy studies were also carried out for NE31, NG31 and HIG. The significant (p < 0.001) increase in in vitro permeability and in vivo anti-inflammatory efficacy of the NG31 formulation was observed as compared with HIG formulation. It can be concluded that the selection of surfactant and cosurfactant on the basis of their emulsification capabilities other than the solubilizing capacity of drug is an important criterion for the formulation of nanoemulsion.Keywords
This publication has 20 references indexed in Scilit:
- Extra-articular features of rheumatoid arthritisMedicine, 2006
- Topical Delivery of Aceclofenac from Lecithin Organogels: Preformulation StudyCurrent Drug Delivery, 2006
- Intraarticular drug delivery in osteoarthritis☆Advanced Drug Delivery Reviews, 2006
- Osteoarthritis: An Overview of the Disease and Its Treatment StrategiesSeminars in Arthritis and Rheumatism, 2005
- Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formulaEuropean Journal of Pharmaceutical Sciences, 2003
- Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitorsEuropean Journal of Pharmacology, 1997
- Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transportJournal of Controlled Release, 1997
- Delivery of a hydrophilic solute through the skin from novel microemulsion systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1997
- Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsionsPharmaceutica Acta Helvetiae, 1996
- Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritisInflammation Research, 1994